Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Express Scripts (ESRX)

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,061,192
  • Shares Outstanding, K 563,860
  • Annual Sales, $ 100,065 M
  • Annual Income, $ 4,517 M
  • 60-Month Beta 0.88
  • Price/Sales 0.54
  • Price/Cash Flow N/A
  • Price/Book 2.53
  • Price/Earnings ttm 11.17
  • Earnings Per Share ttm 8.58
  • Most Recent Earnings 2.43 on 10/31/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 2.67
  • Number of Estimates 10
  • High Estimate 2.77
  • Low Estimate 2.58
  • Prior Year 2.16
  • Growth Rate Est. (year over year) +23.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.11 +0.24%
on 12/20/18
101.73 -9.24%
on 12/03/18
-2.96 (-3.11%)
since 11/20/18
3-Month
91.92 +0.45%
on 10/24/18
101.73 -9.24%
on 12/03/18
-2.71 (-2.85%)
since 09/20/18
52-Week
66.93 +37.95%
on 04/02/18
101.73 -9.24%
on 12/03/18
+18.34 (+24.79%)
since 12/20/17

Most Recent Stories

More News
Express Scripts Has Returned 3.4% Since SmarTrend Recommendation (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 15 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Express Scripts Has Returned 3.4% Since SmarTrend Recommendation (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 14 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Express Scripts Down 3.4% Since SmarTrend Downtrend Call (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 14 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Shares of ESRX Down 3.4% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 14 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
electroCore, Inc. Announces Rebate Agreement with Ascent Health Services for gammaCore Preferred Brand Coverage on all Express Scripts Standard National Formularies

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Ascent Health Services on behalf of Express Scripts, one of the nation's leading pharmacy benefit...

ESRX : 92.33 (-3.62%)
ECOR : 0.93 (-8.13%)
RxRevu Celebrates Unprecedented Growth in 2019

RxRevu achieved unprecedented growth in 2019, advancing its position as the leader in Prescription Decision Support. In only eight months, use of RxRevu's integrated prescription cost transparency solution,...

ESRX : 92.33 (-3.62%)
Downtrend Call Working As Express Scripts Stock Falls 3.4% (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 13 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Express Scripts and Prime Therapeutics Collaborate to Deliver More Affordable Care to More than 100 Million Americans

Leading pharmacy services providers Express Scripts and Prime Therapeutics LLC (Prime) today announced a new three-year collaboration designed to deliver more affordable care for clients and their members...

ESRX : 92.33 (-3.62%)
Cigna Recognized For Being a Supportive Employer for Veterans and Military Spouses

Cigna's commitment to the military and veteran community was recognized on the 2020 Military Friendly® Silver Employer and Military Friendly® Spouse Employer lists by VIQTORY, a service-disabled, veteran-owned...

ESRX : 92.33 (-3.62%)
CI : 191.76 (-4.29%)
Livongo Earns Preferred Status on New Express Scripts Digital Health Formulary

Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it will be included on Express Scripts new,...

ESRX : 92.33 (-3.62%)
LVGO : 25.27 (-6.86%)
Trade ESRX with:

Business Summary

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy...

See More

Key Turning Points

2nd Resistance Point 97.20
1st Resistance Point 94.76
Last Price 92.33
1st Support Level 91.00
2nd Support Level 89.68

See More

52-Week High 101.73
Last Price 92.33
Fibonacci 61.8% 88.44
Fibonacci 50% 84.33
Fibonacci 38.2% 80.22
52-Week Low 66.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar